• Our Research
    • Research Programs
    • Laboratories
    • Faculty
    • Research Sponsors
    • Seminars
    • Scientific Papers
    • Tetramer Biomarker
  • Disease Information
    • Allergies and Asthma
    • Arthritis and Allied Diseases
    • Autoimmune Diseases
    • Cancer
    • Diabetes
    • Heart Disease
    • Lupus
    • Neurological Diseases
    • Other Immune Mediated Diseases
    • Scleroderma
  • Clinical Trials
    • For Clinical Investigators
    • New-Investigator
    • Find A Research Study
    • Diabetes Research Program
    • Clinical Research for Alaskans
    • Frequently Asked Questions (FAQ's)
  • About Us
    • Leadership
    • Achievements
    • Annual Report
    • Fast Facts
    • Employment
    • Contact Information
    • Videos
    • Maps and Directions
    • Virginia Mason Medical Center
    • Site Map
  • News
    • In the News
    • Press Releases
    • Events
    • Newsletters
  • Donate Now
    • To Give Online or Mail a Gift
    • Be A Corporate Sponsor
    • Become a Research Visionary
    • Focused Endowments
    • Donor Events
    • Contact for Donor Information

News

  • In the News
  • Press Releases
  • Events
  • Newsletters

Print Friendly Page
Home

  • Boeing Classic, the Annual PGA TOUR Champions Tour Event, to Benefit BRI in 2010
  • Benaroya Research Institute Receives $7 Million for Vaccine Study
  • Dr. Bettelli Joins BRI to Enhance Multiple Sclerosis Research
  • 2008 Annual Report
  • See New Video to Learn How BRI Tackles Autoimmune Diseases
  • Video Explains Autoimmune Diseases

    See Video on the latest information about autoimmune diseases.  Brook Standford interviews BRI Director Gerald Nepom, MD, PhD, in this segment explaining causes and cures for immune system diseases.

  • New Grants Support Heart Repair, Hepatitis B and Allergy/Asthma Research
  • Life Sciences Discovery Fund Awards BRI $5.57 Million for Autoimmune Disease Research

    Benaroya Research Institute at Virginia Mason (BRI) has been awarded just over $5.57 million from the Washington State Life Sciences Discovery Fund for a major new research initiative, named the Program for Autoimmune Disease Intervention (PADI). Led by BRI Director Gerald Nepom, MD, PhD, this program will focus on applying genetic and immunologic discoveries to benefit patients with autoimmune diseases, such as Type 1 diabetes, multiple sclerosis and systemic lupus erythematosis.

  • BRI Receives $5.3 Million for Allergy Studies

    Benaroya Research Institute at Virginia Mason (BRI)
    recently received a $5.3 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) to further research allergens. The BRI team will work to study immune response to environmental allergens. The scientists will use tetramers to identify and study cells from individuals who are allergic to cat dander, tree and grass pollen, peanuts, mold and others.

  • Upcoming Type 1 Diabetes Screenings

    Learn about the upcoming diabetes screenings being held throughout the Pacific Northwest and find out about regional screening sites.

 
  • Home
  • Diabetes Research
  • Clinical Trials
  • Autoimmune Diseases
  • About Us
  • News
  • Donate Now
  • Our Scientists
  • Find us on Facebook
Contents © 2008 Benaroya Research Institute at Virginia Mason. All rights reserved.
Address: 1201 Ninth Avenue, Seattle, WA 98101-2795 Phone: (206) 583-6525
Terms of Use. Notice of Privacy Practices. Site Design by Fuse IQ.